AMP logo
AMP
Amplifon

Fit4Growth And Consolidation Will Unlock Hearing Aid Potential

AN
AnalystConsensusTarget
AnalystConsensusTarget
Not Invested
Consensus Narrative from 16 Analysts
Published
07 Dec 24
Updated
31 Jul 25
AnalystConsensusTarget's Fair Value
€24.06
38.3% undervalued intrinsic discount
31 Jul
€14.84
Loading
1Y
-47.1%
7D
-25.6%

Author's Valuation

€24.1

38.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Narrative
Updates8

Shared on01 May 25
Fair value Decreased 11%

Read more

Shared on23 Apr 25
Fair value Decreased 0.22%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on17 Apr 25
Fair value Decreased 0.62%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on09 Apr 25
Fair value Decreased 1.19%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on02 Apr 25
Fair value Increased 0.66%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on26 Mar 25
Fair value Decreased 2.42%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on19 Mar 25
Fair value Decreased 2.93%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

Shared on12 Mar 25
Fair value Decreased 8.92%

AnalystConsensusTarget has decreased profit margin from 9.7% to 8.7%.

Read more